Astrazneca opens the 300 million dollar cell treatment facility in Maryland

Astrazneca, as part of its continuous investment of $ 3.5 billion in American innovationThe first United States cell therapy manufacturing facility opened in Maryland to help treat cancer patients.

The UK -based giant said that the new 300 million dollar facility in Rockeville symbolizes its confidence in America as a “global leader in science, manufacturing and economic growth.”

“We understand the importance of doing what we are doing because the souls and health are at stake,” said Bam Cheng, Executive Vice President of Global Operations at Astrazeneca, at the opening of the facility on Monday. “We have chosen this in Maryland because we believe in its amazing talent, its scientific leadership and the spirit of cooperation.”

Astrazeneca to withdraw the Covid-19 vaccine worldwide with a decrease in demand, rare side effects revealed

Once it is run, the site will use a relatively new cancer treatment called Car-T for treatment to help treat Blood cancers Such as lymphoma and leukemia.

Andrew Gordon, one of the cancer survivors that were diagnosed in 2013 with multiple myeloma, said he used car cell therapy to combat the disease after relapse.

Gordon said: “This is really the latest divorce for cancer research,” Gordon said. “As a patient, we are very grateful to Estrazzinica for the work they will do here.”

The study indicates that alternative cancer treatment can replace chemotherapy and surgery

The opening of the new facility comes amid comments made in recent weeks by the CEO of Astrazeneca, Pascal Soriot, about investing in America. He said that the United States, compared to other regions such as Europe, could be more attractive to pharmaceutical companies for investment because of its heavy spending on health care, according to. To Reuters.

“Europe spends a much lower share than the gross domestic product on innovative drugs from the United States, and as a result, it fails to attract (research and development) and manufacture investments, which makes its ability to protect the health of its people at risk,” Soreriot said in a statement.

What are the financial markets screaming about Trump’s tariff

president Donald Trump It has been paid for the largest American innovation-where he recently provided a trillion dollars in American investment, including companies such as Toyota, Amazon, Johnson, Johnson and more. In a list released by the White House of Trump, he wins during the first hundred days of his second term, he admitted the increasing investment of Astrazeneca in American manufacturing.

The $ 3.5 billion pharmaceutical company was announced in research and manufacturing in the United States for the first time in November. It also includes a research and development center In MassachusettsManufacturing specialization in Texas, manufacturing from the next generation of biology in Maryland, and more, according to the pharmaceutical maker.

Get Fox Business on the Go by clicking here

While the American Astrazeneca operations are currently generating about 43 % of its global revenues, the company hopes that the United States will represent half of its global revenues.

“With 4,200 American employees and more than 9 billion doses produced annually via our American manufacturing network, we believe that the future of advanced medicine – and leadership should be built – from here at home,” Astrazneca wrote in a statement.